Mostrar el registro sencillo del ítem
| dc.contributor.author | Palma-Carbajal, Ricardo | |
| dc.contributor.author | Belahnech, Yassin | |
| dc.contributor.author | de-la-Torre-Hernández, José-María | |
| dc.contributor.author | Camarero, Tamara-García | |
| dc.contributor.author | Vegas-Valle, José-Miguel | |
| dc.contributor.author | Murillo, Juan-Rondan | |
| dc.contributor.author | Gómez-Menchero, Antonio | |
| dc.contributor.author | Pérez-de-Prado, Armando | |
| dc.contributor.author | Pinar-Bermúdez, Eduardo | |
| dc.contributor.author | Martín-Lorenzo, Pedro | |
| dc.contributor.author | Jiménez-Mazuecos, Jesus-Manuel | |
| dc.contributor.author | García-San-Román, Koldobika | |
| dc.contributor.author | Vaquerizo, Beatriz | |
| dc.contributor.author | Calviño-Santos, Ramón | |
| dc.contributor.author | Lozano-Ruiz-Poveda, Fernando | |
| dc.contributor.author | Ojeda-Pineda, Soledad | |
| dc.contributor.author | Perea-Armijo, Jorge | |
| dc.contributor.author | Bayon, Jeremias | |
| dc.contributor.author | Goicolea-RuiGómez, Javier | |
| dc.contributor.author | Briales, Juan-H-Alonso | |
| dc.contributor.author | Sanchis, Juan | |
| dc.contributor.author | García-del-Blanco, Bruno | |
| dc.date.accessioned | 2026-08-03T10:28:50Z | |
| dc.date.available | 2026-08-03T10:28:50Z | |
| dc.date.issued | 2026-03-31 | |
| dc.identifier.issn | 1756-1477 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/27123 | |
| dc.description.abstract | BACKGROUND: Percutaneous coronary intervention (PCI) for complex anatomy is increasingly common. The third-generation Ultimaster TANSEI drug-eluting stent (DES) was developed to optimise safety and efficacy in challenging lesions. METHODS: This was a prospective, single-arm, multicentre registry (August 2020-November 2022) of patients with complex lesions - left main, bifurcations, small vessels and long lesions - treated with Ultimaster TANSEI DES and followed for 1 year. The primary endpoint was the device-oriented composite endpoint (DoCE), including cardiac death, target-vessel MI, target-vessel revascularisation (TVR) and stent thrombosis. The secondary endpoint was the patient-oriented composite endpoint (PoCE), including all-cause death, any MI and any revascularisation. RESULTS: In total, 501 patients with 591 complex lesions (mean age 66.7 years; 79.6% male; 33.4% with diabetes) were treated. Lesion types: left main 11%, bifurcations 43.9%, small vessels 40.7%, long lesions 34.3%. At 1 year, incidence rates were: DoCE 3.23 per 100 person-years (95% CI [1.84-5.24]) and PoCE 5.04 per 100 person-years (95% CI [3.26-7.44]). In subgroup analyses, long lesions (>35 mm) showed consistently higher risk: DoCE RR 4.22 (95% CI [1.49-11.95]; p=0.006), PoCE RR 4.93 ([2.10-11.57]; p<0.001), overall mortality RR 4.79 [1.53-15.06]; p=0.007) and TVR RR 17.60 [2.22-139.51]; p<0.001). | |
| dc.language.iso | eng | |
| dc.publisher | RADCLIFFE CARDIOLOGY | |
| dc.rights | Atribución/Reconocimiento-NoComercial 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/deed.es | * |
| dc.title | Ultimaster TANSEI Stent in Complex Coronary Lesions: The EPIC08 TANSEI COMPLEX Study | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 42003940 | |
| dc.relation.publisherversion | https://www.icrjournal.com/articleindex/icr.2025.33 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.15420/icr.2025.33 | |
| dc.journal.title | INTERVENTIONAL CARDIOLOGY-REVIEWS RESEARCH RESOURCES | |
| dc.identifier.essn | 1756-1485 |